The Biotech Patenting and Tech Transfer track has a lot to offer 2011 BIO International Convention Attendees. High level speakers include White House Intellectual Property Enforcement Coordinator Victoria Espinel, European Patent Office Director of Biotechnology Sjoerd Hoekstra, retired Chief Judge of the U.S. Court of Appeals for the Federal Circuit Paul Michel, and former Solicitors General Seth Waxman and Paul Clement to name a few.
I am particularly excited about the breadth of the session content. Issues range from biosimilars, patentability of DNA, and recent Supreme Court decisions. Those representing small biotechs and University Tech Transfer offices can enjoy sessions focused on collaborative R&D, technology transfer, and licensing. Larger biotechs can learn about fighting counterfeiting abroad with the U.S. government and patenting issues in Europe and India. Click on the links below to find out more about these Breakout Sessions:
A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars
Collaborative R&D From the Perspective of Large Multinationals, Universities and Start-ups
Counterfeiting – How Corporations and the Government Can Work Together
European patent and unitary EU patent: the changes ahead
Innovative Collaborations: Deal Structures for Nonprofit/For-Profit Collaborations
Lessons From In-Licensing Partnership: Biotech Company Partners With Global Pharma to Deliver Cutting-Edge Follow-On Biologics
Technology Transfer: New Methods, New Media, New Models for Improving Interactions with Industry
The Myriad Case and the Patentability of Isolated DNA Molecules
